Frontier IP Group chief executive officer Neil Crabb said: “We’re delighted with the rapid progress the agreement with Palintest is making. It has taken less than 18 months from when

Technology is constantly impacting and changing the way the world works. Greater technological innovations are not only changing the way business operates, but also have a significant impact on employees.

A recent article about AI-based drug development, indicates the progressive use of A.I. technologies for the drug production industry, mining the huge amount of data collected from the pharmaceutical companies’

In 2013, US start-up Berg was asked by the Department of Defence to help improve the detection of prostate cancer, a disease which is common among pilots. Less than five

Frontier IP Chief Executive Officer Neil Crabb said: “We are delighted with this news from Exscientia. The acquisition adds to the exciting potential of what the Company can achieve in

Neil Crabb, CEO of Frontier IP Group plc, commented: “Frontier IP is going from strength to strength. There is strong evidence that our distinctive approach to intellectual property commercialisation, designed

Oxford is a hotbed of AI, deep tech, space and medtech talent, capitalising on the university city’s prowess and heritage in research and science. Home to the oldest university in

The examples of AI and its applications in healthcare potentially offer affordable healthcare, efficient clinical trials, improved success rates and a better quality of life. While many of us may

In a key point in its growth strategy, Exscientia, the innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is expanding its Oxford presence to the new Schrödinger